Table 1 Clinical–epidemiological characteristics of the population with CKD according to the NLR level
Characteristics | All (n = 343) | NLR | p value | |
|---|---|---|---|---|
High (n = 50) | Normal (n = 293) | |||
Age (years)* | 78.3 (11.9) | 76.8 (10.8) | 78.5 (12.1) | 0.33 |
Sex** | 0.27 | |||
Female | 127 (37.1) | 15 (30.0) | 112 (38.2) | |
Male | 216 (62.9) | 35 (70.0) | 181(61.8) | |
Hypertension** | 0.60 | |||
Yes | 222 (64.7) | 34 (68.0) | 188 (64.2) | |
No | 121 (35.3) | 16 (32.0) | 105 (35.8) | |
Diabetes** | 0.50 | |||
Yes | 103 (30.0) | 13 (26.0) | 90 (30.7) | |
No | 240 (70.0) | 37 (74.0) | 203 (69.3) | |
CKD stage** | 0.82 | |||
1–2 | 22 (6.4) | 4 (8.0) | 18 (6.1) | |
3a–3b | 311 (90.7) | 45 (90.0) | 266 (90.8) | |
4–5 | 10 (2.9) | 1 (2.0) | 9 (3.1) | |
Laboratory profile | ||||
Serum creatinine (mg/dL)* | 1.4 (0.5) | 1.4 (0.3) | 1.4 (0.5) | 0.92 |
eGFR (ml/min/1.73 m2)* | 47.4 (10.5) | 47.6 (10.3) | 47.4 (10.6) | 0.88 |
Glucose (mg/dL)*** | 90 (83–104) | 88.5 (82–109) | 90 (83–103) | 0.98 |
Total protein (g/dL)* | 7.2 (0.6) | 7.1 (0.6) | 7.3 (0.6) | 0.08 |
Albumin (g/dL)* | 4.1 (0.4) | 4.1 (0.4) | 4.2 (0.4) | 0.12 |
AST (U/L)*** | 23 (19–28) | 23 (16–27) | 23(19–28) | 0.12 |
ALT (U/L)*** | 18(13–24) | 19 (14–24) | 18(13–24) | 0.56 |
Total bilirubin (mg/dL)*** | 0.6 (0.4–0.8) | 0.6 (0.5–0.8) | 0.6 (0.4–0.8) | 0.29 |
Alkaline phosphatase (U/L)*** | 101 (82–128) | 114 (85–148) | 100 (82–124) | 0.03 |
Globulin (g/dL)* | 3.1 (0.7) | 3.1 (0.6) | 3.1 (0.8) | 0.57 |
Hemoglobin (g/dL)* | 12.2 (1.7) | 12.1 (1.7) | 12.2 (1.7) | 0.70 |
Platelets (K/uL)* | 237.9 (82.4) | 260.7 (10.6) | 234.1 (78.1) | < 0.01 |